세계의 D 다이머 검사 시장 보고서(2025년)
D Dimer Testing Global Market Report 2025
상품코드 : 1824368
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

D 다이머 검사 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.4%를 나타내 19억 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 노인 인구 증가, POC(Point-of-Care) 검사(POCT)의 성장, 리스크 평가 알고리즘과의 통합, 인지도 향상과 교육 캠페인, 규제 지침, 표준화에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 진단 강화를 위한 바이오마커의 조합, 신속하고 정확한 결과의 중시, COVID-19 관리에서의 d 다이머 검사, 원격 모니터링과 재택 검사 키트, 지속적인 모니터링, 연속 검사 등을 들 수 있습니다.

향후 5년간의 성장률 5.4%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세장벽은 이탈리아나 한국에서 공급되는 D 다이머 자동분석장치와 시약 비용을 상승시켜 미국 시장을 저해하고 정맥혈전색전증 진단을 늦추고 검사실 운영 비용을 상승시킬 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

예상되는 암의 유병률 증가는 D 다이머 검사 시장 성장의 중요한 촉진요인이 될 것으로 예측됩니다. 암은 이웃 조직에 침윤하거나 다른 장기로 전이하거나 하는 이상 세포의 무질서한 증식을 특징으로 하기 때문에 효과적인 진단·감시 툴이 필요합니다. D 다이머 검사는 진단, 모니터링, 치료에 도움이 될 뿐만 아니라 암의 일반적인 합병증인 혈전 형성의 위험을 평가하는 등 암 환자 관리에 중요한 역할을 하고 있습니다. 2022년 1월 기준 미국 암 협회의 조사에 따르면 2022년 미국의 암에 의한 사망자 수는 60만 9,360명, 새로운 암 이환 환자 수는 190만명이었으며 암 부담은 상당한 것으로 되어 있습니다. 매일 약 1,670명이 사망하는 암의 유병률 증가는 D 다이머 검사 시장 성장의 원동력을 강조합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

D-dimer testing involves a laboratory blood test designed to measure the levels of d-dimer, a protein fragment formed when blood clots break down in the body. This test serves as a diagnostic tool to either confirm or rule out the presence of blood clots, particularly in conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).

The primary categories of d-dimer testing encompass clinical laboratory tests and point-of-care tests. Clinical laboratory tests encompass a broad range of diagnostic procedures conducted on patient samples within laboratory settings. These tests involve various products such as analyzers, reagents, and consumables, employing methods such as enzyme-linked immunosorbent assay (ELISA), latex-enhanced immuno-turbidimetric assays, and others. They serve multiple applications including detecting conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), among others. These tests are utilized by various end-users including hospitals, academic and research institutes, diagnostic centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The d-dimer testing market research report is one of a series of new reports from The Business Research Company that provides d-dimer testing market statistics, including d-dimer testing industry global market size, regional shares, competitors with a d-dimer testing market share, detailed d-dimer testing market segments, market trends, and opportunities, and any further data you may need to thrive in the d-dimer testing industry. This d-dimer testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The d dimer testing market size has grown steadily in recent years. It will grow from $1.47 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the emergence of thrombosis research, improvements in laboratory techniques, clinical validation of d-dimer as a marker, and a shift in diagnostic protocols.

The d dimer testing market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing geriatric population, growth in point-of-care testing (POCT), integration with risk assessment algorithms, increased awareness and education campaigns, regulatory guidance and standardization. Major trends in the forecast period include biomarker combinations for enhanced diagnosis, focus on rapid and accurate results, d-dimer testing in COVID-19 management, remote monitoring and home-based testing kits, continuous monitoring, and serial testing.

The forecast of 5.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of automated D-dimer analyzers and reagents sourced from Italy and South Korea, thereby delaying venous thromboembolism diagnoses and elevating laboratory operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in the prevalence of cancer is poised to be a significant driver for the growth of the d-dimer testing market. Cancer, characterized by uncontrolled proliferation of abnormal cells that can invade neighboring tissues or spread to other organs, necessitates effective diagnostic and monitoring tools. D-dimer testing plays a crucial role in the management of cancer patients, aiding in diagnosis, monitoring, and treatment, as well as assessing the risk of blood clot formation-a common complication in cancer. As of January 2022, research from the American Cancer Society indicates a substantial burden of cancer, with an anticipated 609,360 cancer deaths and 1.9 million new cancer cases in the US in 2022. The increasing prevalence of cancer, with about 1,670 fatalities each day, underscores the driving force behind the growth of the d-dimer testing market.

The increasing number of surgical procedures is anticipated to drive the growth of the D-dimer testing market in the future. A surgical procedure refers to a medical intervention that employs manual or instrumental techniques to address a disease, injury, or condition. The growing prevalence of surgical procedures boosts the demand for D-dimer testing services, as these surgeries carry a risk of thrombosis, making D-dimer testing essential for postoperative monitoring to identify complications early and enhance patient outcomes. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based organization, reported that liposuction remained the most common surgical procedure in 2022, maintaining its ranking from 2021, with over 2.3 million procedures performed, marking a 21.1% increase. Thus, the rising demand for surgical procedures is propelling the growth of the D-dimer testing market.

Major players in the d-dimer testing market are actively pursuing a strategic partnership approach to secure exclusive rights to d-dimer testing solutions, gaining a competitive advantage in the market. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative example is the partnership between SphingoTec GmbH, a Germany-based biotechnology company, and Rivaara Labs Pvt Ltd., an India-based medical laboratory and healthcare company. Established in March 2022, this partnership grants Rivaara exclusive rights to market and distribute SphingoTec's point-of-care tests featuring innovative biomarkers in the Indian subcontinent. These biomarkers include proenkephalin (penKid) for kidney function assessment, bioactive adrenomedullin (bio-ADM) for endothelial function evaluation, and dipeptidyl peptidase 3 (DPP3) as a biomarker for cardiac depression. These pioneering markers, along with commonly used parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH, enhance diagnostic capabilities.

Leading companies in the D-dimer testing market are creating innovative products, such as D-dimer test kits, to enhance the accuracy and speed of diagnosing blood clot-related conditions. A D-dimer test kit is a medical diagnostic tool used to measure the levels of D-dimer, a fibrin degradation product, in the blood, aiding in the assessment of blood clots and conditions like deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. For example, in July 2024, Bionote Inc., a South Korea-based manufacturer of medical equipment, launched the Vcheck D-dimer 5 Tests/Kit. This new D-dimer 5-Test Kit, designed specifically for Vcheck immunodiagnostic equipment, is tailored for veterinary clinics. It assists in diagnosing conditions such as thrombosis and disseminated intravascular coagulation (DIC), making it particularly suitable for smaller clinics with fewer emergency cases.

In March 2023, Werfen S.A., a leading diagnostic company based in Spain, successfully acquired Immucor Inc. for a significant sum of $2 billion. This strategic acquisition was pursued by Werfen with the objective of broadening its range of products and reinforcing its standing within the global market for transfusion and transplantation diagnostics. The acquisition of Immucor Inc., a distinguished US-based manufacturer known for producing d-dimer test kits, encompassing enzyme-linked immunosorbent assay (ELISA) technology, as well as transfusion and transplant diagnostic products, is expected to provide Werfen with access to Immucor's extensive global presence and resources.

Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMerieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the d dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the d dimer testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The d-dimer testing market consists of revenues earned by entities by providing services such as sample collection, sample processing, exclusion of blood clots, and risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The d-dimer testing market also includes sales of d-dimer assay kits, d-dimer rapid tests, automated d-dimer analyzers, and point-of-care test kits that are used in providing d-dimer testing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

D Dimer Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on d dimer testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for d dimer testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The d dimer testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. D Dimer Testing Market Characteristics

3. D Dimer Testing Market Trends And Strategies

4. D Dimer Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global D Dimer Testing Growth Analysis And Strategic Analysis Framework

6. D Dimer Testing Market Segmentation

7. D Dimer Testing Market Regional And Country Analysis

8. Asia-Pacific D Dimer Testing Market

9. China D Dimer Testing Market

10. India D Dimer Testing Market

11. Japan D Dimer Testing Market

12. Australia D Dimer Testing Market

13. Indonesia D Dimer Testing Market

14. South Korea D Dimer Testing Market

15. Western Europe D Dimer Testing Market

16. UK D Dimer Testing Market

17. Germany D Dimer Testing Market

18. France D Dimer Testing Market

19. Italy D Dimer Testing Market

20. Spain D Dimer Testing Market

21. Eastern Europe D Dimer Testing Market

22. Russia D Dimer Testing Market

23. North America D Dimer Testing Market

24. USA D Dimer Testing Market

25. Canada D Dimer Testing Market

26. South America D Dimer Testing Market

27. Brazil D Dimer Testing Market

28. Middle East D Dimer Testing Market

29. Africa D Dimer Testing Market

30. D Dimer Testing Market Competitive Landscape And Company Profiles

31. D Dimer Testing Market Other Major And Innovative Companies

32. Global D Dimer Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The D Dimer Testing Market

34. Recent Developments In The D Dimer Testing Market

35. D Dimer Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기